Michigan Institute for Clinical and Health Research (MICHR) (TL1)

密歇根大学临床和转化 科学奖（UM CTSA）将集中在世界上最优秀的研究之一的强大优势 支持和促进临床和转化研究的机构。UMTSA将在 临床研究促进中心（Center for Advancement of Clinical Research，CACR）绝大多数UM 学校，学院和研究所正在参与UM CTSA，包括商学院， 牙科，医学，护理，信息和公共卫生，工程学院，药学院， 和文学，科学和艺术，运动学系，社会研究所， 生命科学研究所。大学拥有的卫生系统，其中包括大型，综合 门诊和住院设施，以及管理式医疗保险公司（M-CARE）， 为与UM CTSA建立强有力的伙伴关系做出了重大贡献。UM CTSA的能力， 为临床和转化研究人员提供强大的“第二家园”， 大学的单位是来自汇集重要的机构资产，并给予UM CTSA 主任和科学审查委员会有权将这些资源分配给有价值的受训人员， 教师和研究项目。除了赠款资源外，该机构还提供了11个以上的资金， 每年100万美元的实物支助、费用分摊、对试点和招募方案的支助，以及 装修费用。各部门和单位每年为教师的努力贡献另外1600万美元， CTSA可以资助试点研究、教育和“迷你K计划”，而不需要支付费用。 格兰特.为了完成UM CTSA的使命，CACR及其 主任（补助金的主要研究者）将被修改为跨机构。CACR将得到加强 通过机构授权为UM CTSA提供“会员资格”（类似于二级任命） 获奖者我们最近更新的GCRC，K-12和K-30计划将被纳入UM CTSA，根据RFA的要求。UM CTSA建立在交叉研究主题之上， 形式新颖的临床和转化方法学项目，提供临床和转化 技术核心，以及一个试点和合作赠款计划。重新配置的临床研究单位 将容纳参与者和临床互动。生物统计与设计咨询单位或核心， 伦理、监管知识和支持、社区参与、临床翻译（II类 翻译），儿科研究，健康差异。最后，一个强大的研究教育和 培训核心将为教师，学生和工作人员提供职业发展和培训。

The University of Michigan Clinical and Translational Sciences Award (UM CTSA) will focus the formidable strengths of one of the world finest research institutions on supporting and facilitating clinical and translational research. The UM CTSA will be housed in the Center for Advancement of Clinical Research (CACR). The overwhelming majority of UM schools, colleges, and institutes are participating in the UM CTSA, including the Schools of Business, Dentistry, Medicine, Nursing, Information, and Public Health, the Colleges of Engineering, Pharmacy, and Literature, Science and Arts, the Division of Kinesiology, the Institute of Social Research, and the Life Sciences Institute. The University-owned Health System, which includes large, integrated outpatient and inpatient facilities, as well as a managed care insurance company (M-CARE), is contributing significantly to a strong partnership with the UM CTSA. The ability of the UM CTSA to provide a robust "second home" for clinical and translational researchers from these many different units of the University is derived from pooling significant institutional assets, and giving the UM CTSA Director and Scientific Review Committee the authority to distribute these resources to worthy trainees, faculty, and research projects. In addition to the grant resources, the institution is contributing over 11 million per year of in-kind support, cost-sharing, support of pilot and recruitment programs, and renovation costs. Departments and units are contributing another 16 million annually in faculty effort, so that the CTSA can grant effort for pilot studies, education and "mini-K programs" without cost to the grant. To accomplish the mission of the UM CTSA, the reporting lines and authority of CACR and its director (the PI of the grant) will be modified to be trans-institutional. CACR will be strengthened through institutional authority to offer "membership" (akin to secondary appointments) for UM CTSA awardees. Our recently renewed GCRC, K-12, and K-30 programs will be incorporated into the UM CTSA, as required by the RFA. The UM CTSA is built on cross-cutting Research Themes, which in turn form Novel Clinical and Translational Methodology Projects, the provision of Clinical and Translational Technical Cores, and a Pilot and Collaborative Grant Program. A reconfigured Clinical Research Unit will house Participant and Clinical Interactions. Consultative Units or Cores in Biostatistics and Design, Ethics, Regulatory Knowledge and Support, Community Engagement, Clinical Translation (Type II Translation), Research in Pediatrics, and Health Disparities. Finally, a strong Research Education and Training Core will provide career development and training for faculty, students, and staff.